Delivery Order SPE2DB20D3101-SPE2DB21FK1Q4

Award Date 8/6/21
Potential Completion Date 8/9/21
Potential Value $8.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Xarelto 10 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The award has a ceiling value of $6,649.59 and a period of performance through December 6, 2023. This is a delivery order contract, with a firm fixed price pricing type. The contract was awarded without any set-aside designation,...
This federal contract award is for the delivery of Xarelto 10 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical division. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,931.53 and an ultimate completion date of October 21, 2024. It is a delivery order with a firm fixed price pricing type, and there is no set-aside designation indicated. Amerisourcebergen holds a...
This federal contract award is for the delivery of Xarelto 10 mg tablets to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $46,376.23, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Firm Fixed Price Delivery Order with a period of performance through February 27, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that is a subsidiary of Cencora, Inc. The contract has a ceiling value of $7,579.59 and an ultimate completion date of January 28, 2022. It is a firm fixed-price delivery order contract, without any set-aside designations. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $15,440.17 and a completion date of May 1, 2024. It is a delivery order contract with a firm fixed price pricing type. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent...
The federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $23,769.31 and a completion date of March 1, 2024. The contract was awarded on February 29, 2024, and there was no set-aside designation used. Amerisourcebergen Drug Corp holds a...
This federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA) from Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $8,461.30 firm fixed-price delivery order has a completion date of May 3, 2023. The contract is not designated under any set-aside program. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of Xarelto 10 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $34,065.70, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract does not have a set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4,562,450,615 units of Xarelto 10 mg tablets. The contract has a ceiling value of $3,085.07 and a completion date of October 12, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $11,765.12 firm fixed-price delivery order is for the supply of Xarelto 20 mg tablets, a medication used to treat cardiovascular health conditions. The contract has an ultimate completion date of February 29, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB21FK1Q4
    Delivery Order

This federal contract award is for the delivery of Xarelto 10 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract has a ceiling value of $8,155.35 and an ultimate completion date of August 9, 2021. The contract was awarded on a firm fixed-price basis without any set-aside designation, indicating open competition.

Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award references critical medical commodities such as specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, for similar medical products and prescription drugs.

Generated 2/27/25, 11:21 AM